NCT04881760: A Study of LY3437943 in Participants Who Have Obesity or Are Overweight
- State
- Completed
- Phase
- Phase 2
- People
- 338 taking part
- Started
- 20 May 2021
- Primary completion
- 16 May 2022
- Arms
- 1 milligram (mg) LY3437943, 4 mg LY3437943 (2 mg), 4 mg LY3437943, 8 mg LY3437943 (2 mg), 8 mg LY3437943 (4 mg), 12 mg LY3437943 (2 mg)
- Results
- Posted on the registry
- 11 May 2021: Trial registered
- 20 May 2021: Trial started
- 22 Nov 2022: Trial completed
- 13 Sep 2023: Trial results posted